Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
biotech ipos
clinical trials
life sciences
national blog main
rare diseases
2
×
10x genomics
boston
boston blog main
boston top stories
deals
desmoid tumors
dihydroergotamine
dyne therapeutics
fda
generic drugs
investing
medical device
metacrine
myotonic dystrophy type 1
new york blog main
new york top stories
nirogacestat
nonalcoholic steatohepatitis
pfizer
rare disease drugs
renaissance capital
salk institute
san diego blog main
san diego top stories
san francisco
san francisco blog main
san francisco top stories
satsuma pharmaceuticals
springworks therapeutics
startups
ulcerative colitis
What
ipo
2
×
biotech
boost
brings
companies
company
developing
disorders
drug
dyne
dyne’s
followed
genetic
genomics
haul
led
life
markets
medicines
million
muscle
muscular
preclinical
public
raised
rare
satsuma
science
springworks
stage
street
therapeutics
topped
upsized
wall
way
wednesday
week
week’s
welcomed
Language
unset
Current search:
ipo
×
" rare diseases "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
